Article
Absence of p16 and p27 gene rearrangements and mutations in de novo myelodysplastic syndromes.
European journal of haematology - 1 Sept 2005
Papageorgiou Sotirios G, Pappa Vassiliki, Papageorgiou Efstathios, Tsirigotis Panagiotis, Kontsioti Frida, Panani Anna, Dervenoulas John, Economopoulos Theofanis
Abstract excerpt
Myelodysplastic syndromes (MDS) represent a group of clonal hematopoietic disorders characterized by dyshemopoiesis and frequent evolution to acute leukemia. Tumor suppressor gene inactivation may be involved in MDS pathogenesis. The two families of cyclin-dependent kinase inhibitors (CDKIs) (INK4 family of p15, p16, p18 and p19 and CIP/KIP family of p21, p27 and p57) that negatively regulate cell cycle...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
